Bottle Label 10 mg (71610 0546 60)
Terazosin
Product Images NDC 71610-546
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 71610-546). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)
Figure 1 (Terazosin Hydrochloride Capsules 2)
Figure 2 (Terazosin Hydrochloride Capsules 3)
Figure 3 (Terazosin Hydrochloride Capsules 4)
This appears to be a table or graph with measurements taken over a time period of 30 months. The units are indicated as mL/sec. However, without additional information or context, it is impossible to determine the specific subject or purpose of the data.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
